Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rapid Micro Biosystems (RPID) Free Cash Flow (2020 - 2025)

Historic Free Cash Flow for Rapid Micro Biosystems (RPID) over the last 6 years, with Q3 2025 value amounting to -$9.1 million.

  • Rapid Micro Biosystems' Free Cash Flow fell 341.15% to -$9.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$38.6 million, marking a year-over-year increase of 1506.85%. This contributed to the annual value of -$45.5 million for FY2024, which is 300.05% up from last year.
  • Per Rapid Micro Biosystems' latest filing, its Free Cash Flow stood at -$9.1 million for Q3 2025, which was down 341.15% from -$10.1 million recorded in Q2 2025.
  • Over the past 5 years, Rapid Micro Biosystems' Free Cash Flow peaked at -$8.8 million during Q3 2024, and registered a low of -$19.8 million during Q3 2021.
  • Over the past 5 years, Rapid Micro Biosystems' median Free Cash Flow value was -$11.5 million (recorded in 2021), while the average stood at -$12.9 million.
  • Per our database at Business Quant, Rapid Micro Biosystems' Free Cash Flow plummeted by 18050.99% in 2021 and then soared by 4459.5% in 2023.
  • Quarter analysis of 5 years shows Rapid Micro Biosystems' Free Cash Flow stood at -$14.9 million in 2021, then grew by 16.07% to -$12.5 million in 2022, then increased by 20.46% to -$9.9 million in 2023, then decreased by 0.93% to -$10.0 million in 2024, then rose by 8.82% to -$9.1 million in 2025.
  • Its Free Cash Flow stands at -$9.1 million for Q3 2025, versus -$10.1 million for Q2 2025 and -$9.4 million for Q1 2025.